Page last updated: 2024-10-29

isoniazid and Hepatitis B Virus Infection

isoniazid has been researched along with Hepatitis B Virus Infection in 17 studies

Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).

Research Excerpts

ExcerptRelevanceReference
"The present study is designed to conduct, the analysis on the curative effect of Lamivudine in treating liver function lesion caused by hepatitis B combined anti-TB drugs."9.27Clinical effect of lamivudine in treating liver function lesion caused by hepatitis B combined with Anti-TB drugs. ( Han, Y; Xia, S; Zhou, J, 2018)
"The present study is designed to conduct, the analysis on the curative effect of Lamivudine in treating liver function lesion caused by hepatitis B combined anti-TB drugs."5.27Clinical effect of lamivudine in treating liver function lesion caused by hepatitis B combined with Anti-TB drugs. ( Han, Y; Xia, S; Zhou, J, 2018)
"Isoniazid did not cause greater hepatotoxicity in hepatitis B carriers than in noncarriers."5.27Isoniazid prophylaxis in hepatitis B carriers. ( London, WT; Lustbader, ED; McGlynn, KA; Murphy, EC; Sharrar, RG, 1986)
" Key recent developments to address HIV-related TB among PWIDs include the use of simplified symptom-based algorithm to provide isoniazid-preventive therapy, molecular DNA detection methods for Mycobacterium tuberculosis and the immediate provision of antiretroviral therapy within the first 2 weeks of initiation of anti-TB treatment."4.88Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services. ( Getahun, H; Gunneberg, C; Raviglione, M; Sculier, D; Verster, A, 2012)
" Latent tuberculosis was diagnosed at baseline and the patient was treated with isoniazid for 9 months."3.76Etanercept in a patient with severe psoriasis and latent viral hepatic disease and latent tuberculosis. ( Ferguglia, G; Laria, G; Prestinari, F, 2010)
"To determine whether inactive hepatitis B surface antigen (HBsAg) carriers are at a higher risk of drug-induced hepatotoxicity than control subjects during antituberculosis treatment with standard short-course regimens of isoniazid, rifampin, ethambutol, and/or pyrazinamide."3.73Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy. ( Choi, MS; Chung, MP; Kim, H; Koh, WJ; Kwon, OJ; Lee, BH; Suh, GY, 2005)
"Serologic markers for hepatitis viruses were studied in 40 children who developed acute hepatitis during antituberculosis therapy with rifampin and isoniazid, with the aim of assessing the contributory role of these viruses toward producing hepatic injury."3.68Hepatotoxicity of rifampin and isoniazid. Is it all drug-induced hepatitis? ( Govil, YC; Kumar, A; Mehotra, R; Misra, PK; Rana, GS, 1991)
" The main factors increasing the risk of hepatic toxicity was a high dosage of INH and overall malnutrition."1.28[Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus]. ( Boguikouma, JB; Gahouma, D; Gendrel, D; Mouba, JF; Moussavou, A; Nardou, M, 1989)
"Isoniazid did not cause greater hepatotoxicity in hepatitis B carriers than in noncarriers."1.27Isoniazid prophylaxis in hepatitis B carriers. ( London, WT; Lustbader, ED; McGlynn, KA; Murphy, EC; Sharrar, RG, 1986)

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19904 (23.53)18.7374
1990's3 (17.65)18.2507
2000's4 (23.53)29.6817
2010's6 (35.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, Y1
Xia, S1
Zhou, J1
Thee, S1
Krüger, R1
von Bernuth, H1
Meisel, C1
Kölsch, U1
Kirchberger, V1
Feiterna-Sperling, C1
Adamu, B1
Abdu, A1
Abba, AA1
Borodo, MM1
Tleyjeh, IM1
Cheung, I1
Collins, RA1
Prestinari, F1
Ferguglia, G1
Laria, G1
Getahun, H1
Gunneberg, C1
Sculier, D1
Verster, A1
Raviglione, M1
Lee, BH1
Koh, WJ1
Choi, MS1
Suh, GY1
Chung, MP1
Kim, H1
Kwon, OJ1
Valencia Ortega, ME1
Yu, WC1
Lai, ST1
Chiu, MC1
Chau, TN1
Ng, TK1
Tam, CM1
Walker, PF1
Türktaş, H1
Unsal, M1
Tülek, N1
Orüç, O1
Patel, PA1
Voigt, MD1
Kumar, A1
Misra, PK1
Mehotra, R1
Govil, YC1
Rana, GS1
Wu, JC1
Lee, SD1
Yeh, PF1
Chan, CY1
Wang, YJ1
Huang, YS1
Tsai, YT1
Lee, PY1
Ting, LP1
Lo, KJ1
Gendrel, D1
Nardou, M1
Mouba, JF1
Gahouma, D1
Moussavou, A1
Boguikouma, JB1
McGlynn, KA1
Lustbader, ED1
Sharrar, RG1
Murphy, EC1
London, WT1
Seki, S1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
One-month Latent Tuberculosis Treatment for Renal Transplant Candidates[NCT05411744]Phase 425 participants (Anticipated)Interventional2022-07-01Recruiting
Prophylactic Use of Entecavir to Reduce Hepatitis Flare in Highly Viremic HBV Patients With Active Tuberculosis Receiving Anti-tuberculous Treatment[NCT01724723]Phase 450 participants (Anticipated)Interventional2012-12-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for isoniazid and Hepatitis B Virus Infection

ArticleYear
Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis.
    The Cochrane database of systematic reviews, 2014, Mar-04, Issue:3

    Topics: Antibiotic Prophylaxis; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Hepatitis B;

2014
Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services.
    Current opinion in HIV and AIDS, 2012, Volume: 7, Issue:4

    Topics: Antitubercular Agents; Chemoprevention; Comorbidity; Harm Reduction; Hepatitis B; Hepatitis C; HIV I

2012

Trials

1 trial available for isoniazid and Hepatitis B Virus Infection

ArticleYear
Clinical effect of lamivudine in treating liver function lesion caused by hepatitis B combined with Anti-TB drugs.
    Pakistan journal of pharmaceutical sciences, 2018, Volume: 31, Issue:4(Special)

    Topics: Adult; Aged; Antitubercular Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B

2018

Other Studies

14 other studies available for isoniazid and Hepatitis B Virus Infection

ArticleYear
Screening and treatment for tuberculosis in a cohort of unaccompanied minor refugees in Berlin, Germany.
    PloS one, 2019, Volume: 14, Issue:5

    Topics: Adolescent; Berlin; Chemoprevention; Female; Germany; Hepatitis B; Humans; Isoniazid; Latent Tubercu

2019
Projects related to respiratory infectious diseases, gastrointestinal diseases, viral hepatitis, and miscellaneous infection.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2015, Volume: 21 Suppl 4

    Topics: Antimicrobial Cationic Peptides; Cathelicidins; Guanine; Helicobacter Infections; Hepatitis B; Human

2015
Etanercept in a patient with severe psoriasis and latent viral hepatic disease and latent tuberculosis.
    American journal of clinical dermatology, 2010, Volume: 11 Suppl 1

    Topics: Antitubercular Agents; Etanercept; Hepatitis B; Humans; Immunoglobulin G; Immunologic Factors; Isoni

2010
Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
    Chest, 2005, Volume: 127, Issue:4

    Topics: Adult; Antitubercular Agents; Carrier State; Case-Control Studies; Chemical and Drug Induced Liver I

2005
[Medicine and television: a diagnosis history].
    Medicina clinica, 2005, Jun-11, Volume: 125, Issue:2

    Topics: Adult; Antitubercular Agents; Cholestasis, Intrahepatic; Diagnostic Errors; Hepatitis B; Hepatitis C

2005
Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2006, Volume: 10, Issue:7

    Topics: Antitubercular Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Isoniazid;

2006
Health care of Indochinese refugees.
    Minnesota medicine, 1984, Volume: 67, Issue:12

    Topics: Cambodia; Hepatitis B; Humans; Isoniazid; Laos; Parasitic Diseases; Refugees; Tuberculosis; United S

1984
Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis.
    Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1994, Volume: 75, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; D

1994
Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States.
    The American journal of gastroenterology, 2002, Volume: 97, Issue:5

    Topics: Adolescent; Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child

2002
Hepatotoxicity of rifampin and isoniazid. Is it all drug-induced hepatitis?
    The American review of respiratory disease, 1991, Volume: 143, Issue:6

    Topics: Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Female; Hepatitis A; Hepatitis B; H

1991
Isoniazid-rifampin-induced hepatitis in hepatitis B carriers.
    Gastroenterology, 1990, Volume: 98, Issue:2

    Topics: Carrier State; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female

1990
[Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus].
    Archives francaises de pediatrie, 1989, Volume: 46, Issue:9

    Topics: Adolescent; Africa; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Combinatio

1989
Isoniazid prophylaxis in hepatitis B carriers.
    The American review of respiratory disease, 1986, Volume: 134, Issue:4

    Topics: Adult; Alanine Transaminase; Asia, Southeastern; Carrier State; Child; Hepatitis B; Hepatitis B Surf

1986
[Study of the treatment of liver damage due to several causes in tuberculosis, using ornithine-aspartate].
    Iryo, 1966, Volume: 20, Issue:4

    Topics: Aspartic Acid; Blood Transfusion; Female; Hepatitis; Hepatitis B; Humans; Isoniazid; Male; Ornithine

1966